Description
Gonadorelin is a synthetic decapeptide identical to gonadotropin-releasing hormone (GnRH) that is used as a research tool to study hypothalamic–pituitary–gonadal (HPG) axis signaling. As a GnRH receptor agonist, gonadorelin is applied in experimental systems to characterize receptor activation, downstream intracellular signaling, and regulated secretion of pituitary gonadotropins such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Gonadorelin peptide research commonly supports neuroendocrinology and receptor biology studies focused on pulsatile hormone control, feedback regulation, and endocrine network dynamics.
In vitro assays often quantify receptor binding, second-messenger responses, and gene expression changes in GnRH receptor–expressing cells. In animal models, researchers may measure LH/FSH release profiles over time, evaluate pulse frequency effects, and assess endocrine feedback markers relative to vehicle-treated controls. These systems matter in laboratory research because they provide measurable endpoints for GPCR signaling, hormone release kinetics, and the mechanisms by which neuronal inputs coordinate reproductive endocrine function under controlled conditions.
For research use only. Not for human consumption.
References:
Flanagan CA et al., Front Endocrinol (Lausanne), 2017;8:274
Millar RP et al., Front Neuroendocrinol, 2004;25(1):1–28
Limonta P et al., Peptides, 1999;20(3):347–363
Reviews
There are no reviews yet.